Loading...

Devintec SAGL

is a privately owned pharmaceutical company based in Lugano, Switzerland.

Our business is based on advanced Research & Development that leads to discovering, developing and successively licensing innovative Substance-based Medical Devices (SMD).

We apply the highest Clinical & Regulatory standards that have brought to life +20 projects of innovative evidence-based medical devices.

0
Trials in clinical development
0%
Turnover invested in R&D in 2022
0
Sponsored Clinical Trials
0
Journal Publications
0
Studies presented at Scientific Congresses

MARKET FOCUS

Mild Psoriasis & Mild Atopic Dermatitis
  • Rapidly increasing population across the globe
  • Growing incidence of skin allergies and chronic disorders
  • Increasing prevalence of atopic disorders
  • High healthcare spending and increasing government support for research development
  • Rise of skin irritants such as soaps, detergents, perfumes, cosmetics and even water may inflame the skin

Global Atopic Dermatitis Treatment Market was valued
at $11.8 billion in 2021

Expected to grow at a CAGR of 13.3% during 2021-2026 period

Psoriasis market is expected to recover from 2020 decrease due to lockdowns and reach $24.4 billion in 2023

Expected to grow at a CAGR of 9.5% from 2021 to 2023

PRODUCTS

Dermasectan & sorisen

  • Enter the growing Derma Drug Global Market with our unique and patented product in Europe

  • Innovative product in a market where there is a significant unmet need to develop new efficacious and safe treatments for Mild Psoriasis or AD patients

  • Unique product that creates an epidermal barrier effect helping the skin to restore its natural features and protecting it from the barrier breach

  • Allow the use of a single effective treatment that targets the vicious inflammatory cycle of psoriasis or AD

  • Safe and effective treatment, that will reduce the use of less effective treatments and those that come with side effects

CHAIRMAN & ADVISORY BOARD PROFILES

STEFANO VERALDI

Associate Professor at the Department of Medical-Surgical Physiopathology and Transplantation of the University of Milan

Research Interest
Acne; and infectious and parasitic skin diseases, sun burn, psoriasis

Membership

  • President of the Italian Acne Board (I.A.B.)
  • Secretary of the Associazione Lombarda di Dermatologia e Venereologia (A.L.D.E.V.)
  • Chairman and Co-Chairman of the Asia Pacific Acne Leaders Summit (A.P.A.L.S.)
  • Member of the European Severe Acne Board & Rosacea Global Advisory Board

Publications
Author of 29 books, 81 chapters and 448 articles in the most prestigious international publications

RAMON GRIMALT

Professor at International University of Catalunia

Research Interest
Pediatric Dermatology, accredited by more than 60 publications; and Hyperhidrosis, skin allergy and dermatological surgery. His current line of research is focused on Trichology and medical informatics.

Membership
He’s member of eighteen international scientific societies, academies.

Publications

  • Guest lecturer in 160 international congresses and in 50 national ones
  • Chairman of 60 international congresses and has presented medical papers at 145 international and 86 national congresses
  • Scientific publications include 11 books
  • Scientific reviewer for 7 international scientific journals

GIAMPIERO GIROLOMONI

Director of complex O.U. Dermatology/Department of Biomedical and Surgical Sciences. Ordinary professor at Verona university

Research Interest
Psoriasis and immunology

Publications

  • Authored a wide number of publication in international journals with high I.F.
  • Author of twelve international books or handbooks and national books too.

JACEK C. SZWPIETOWSKI

MD, PhD, Head Department of Dermatology, Venereology and Allergology, Wroclaw Medical University

Research Interest
His research interest includes: Itch/Pruritus, Psychodermatology, Hidradenitis Suppurativa, Chronic Cutaneous Inflammation, Mycology

Membership
He’s member of twelve international scientific societies, academies

Publications
Authored and co-authored of more than 400 scientific articles, 12 books, more than 70 book chapters and more than 300 congress communications